Edition:
United States

WRIGHT MED GP NV (WMGI.DF)

WMGI.DF on NASD ADF

23.79USD
7 Dec 2016
Change (% chg)

$0.07 (+0.30%)
Prev Close
$23.72
Open
$23.78
Day's High
$23.86
Day's Low
$23.16
Volume
104,286
Avg. Vol
416,888
52-wk High
$25.50
52-wk Low
$15.02

Latest Key Developments (Source: Significant Developments)

Wright Medical Group reports 2016 Q3 results and updates guidance
Wednesday, 2 Nov 2016 04:05pm EDT 

Wright Medical Group Nv : Wright Medical -maintaining existing midpoint of net sales from continuing operations for 2016 guidance but narrowing range to approximately $677 million to $683 million . Wright Medical Group NV says increasing its full-year 2016 non-gaap adjusted ebitda from continuing operations to be in range of $43 million to $48 million . Wright Medical Group NV says anticipates non-gaap adjusted loss per share from continuing operations for 2016 of $0.52 to $0.47 . Fy2016 earnings per share view $-0.48, revenue view $683.6 million -- Thomson Reuters I/B/E/S . Wright Medical Group NV Reports 2016 third quarter financial results and updates 2016 guidance . Q3 loss per share $0.51 from continuing operations .Q3 sales $157.3 million.  Full Article

Wright Medical Group announces entry into metal-on-metal hip litigation settlement agreement
Wednesday, 2 Nov 2016 04:05pm EDT 

Wright Medical Group Nv :Wright Medical Group NV announces entry into metal-on-metal hip litigation settlement agreement.  Full Article

Wright Medical Group says Q2 loss per share $0.41 from continuing operations
Tuesday, 2 Aug 2016 08:16pm EDT 

Wright Medical Group Nv : Wright medical group n.v. Reports 2016 second quarter financial results and increases 2016 guidance . Q2 sales $171 million . Q2 loss per share $0.41 from continuing operations . Sees fy 2016 sales $675 million to $685 million . Fy2016 earnings per share view $-0.61, revenue view $713.1 million -- Thomson Reuters I/B/E/S . Sees full-year 2016 non-gaap adjusted ebitda from continuing operations $40 million to $45 million . Anticipates adjusted cash loss per share from continuing operations for full-year 2016 of $0.54 to $0.47 .Q2 earnings per share view $-0.22, revenue view $172.5 million -- Thomson Reuters I/B/E/S.  Full Article

Wright Medical Group says Q2 loss per share $0.41 from continuing operations
Tuesday, 2 Aug 2016 04:05pm EDT 

Wright Medical Group Nv : Wright medical group n.v. Reports 2016 second quarter financial results and increases 2016 guidance . Q2 sales $171 million . Q2 loss per share $0.41 from continuing operations . Sees fy 2016 sales $675 million to $685 million . Fy2016 earnings per share view $-0.61, revenue view $713.1 million -- Thomson Reuters I/B/E/S . Sees full-year 2016 non-gaap adjusted ebitda from continuing operations $40 million to $45 million . Anticipates adjusted cash loss per share from continuing operations for full-year 2016 of $0.54 to $0.47 .Q2 earnings per share view $-0.22, revenue view $172.5 million -- Thomson Reuters I/B/E/S.  Full Article

Wright Medical Group says Corin to acquire its large joints business
Monday, 11 Jul 2016 01:45am EDT 

Wright Medical Group Nv : Wright Medical Group N.V. announces binding offer under which corin orthopaedics holdings limited would acquire Wright's large joints business . Corin would acquire all of legacy tornier large joints business for a purchase price of 29.7 million euros in cash . Net after-tax proceeds after payment of estimated transaction and transition costs, to be about $20 million . Maintaining its previously communicated guidance for 2016 adjusted ebitda from continuing operations .After closing, tornier large joints business will continue to be headquartered in montbonnot, France.  Full Article

Wright Medical says reconfirmed 2016 financial guidance
Thursday, 16 Jun 2016 04:12pm EDT 

Wright Medical Group NV :Says reconfirmed its financial guidance for full-year 2016 as provided in its earnings release issued on May 4.  Full Article

Wright Medical says issued $395 mln of senior notes due 2021
Wednesday, 25 May 2016 04:21pm EDT 

Wright Medical Group Nv : On May 20, 2016, co issued $395 million aggregate principal amount of 2.25% cash convertible senior notes due 2021- SEC filing . Notes will pay interest at a rate of 2.25% per year beginning on November 15, 2016 .Notes mature on November 15, 2021.  Full Article

Tornier NV updates FY 2015 guidance
Wednesday, 4 Nov 2015 04:00pm EST 

Tornier NV:Anticipates pro forma net sales for FY 2015 of approximately $636 million to $642 million.Anticipates FY 2015 pro forma adjusted EBITDA from continuing operations, as described in the GAAP to non-GAAP reconciliation provided later in this release, of negative $(13.0) million to negative $(17.0) million.FY 2015 revenue of $414.1 million and EBITDA of $(23.5) million - Thomson Reuters I/B/E/S.  Full Article

Tornier NV lowers FY 2015 revenue guidance; Widens FY 2015 EPS guidance
Tuesday, 5 May 2015 04:01pm EDT 

Tornier NV:Projects FY 2015 constant currency revenue expected to be in the range of $304 to $312 million.Says FY 2015 reported revenue is projected to be in the range of $334.0 to $344.0 million.Projects FY 2015 earnings per share expected to be in the range of a loss of $(0.60) to $(0.40) per share.Projects FY 2015 adjusted EBITDA guidance to be in the range of $35 to $38 million.FY 2015 revenue of $347.79 million and EBITDA of $35.78 million and EPS of ($0.39) - Thomson Reuters I/B/E/S.  Full Article

Tornier announces U.S. FDA clearance of Simpliciti Shoulder System
Tuesday, 10 Mar 2015 04:00pm EDT 

Tornier NV:Has received clearance from the U.S. Food and Drug Administration.Says to market Simpliciti Shoulder System, which is unique, bone sparing total shoulder arthroplasty system designed to treat patients experiencing severe shoulder joint pain, compromised range of motion, loss of strength and functionality.This novel, first to market system in the United States provides surgeons with an efficient, repeatable surgical technique that is intended to preserve both the patient's native bone and avoid further trauma to the surrounding soft tissue.  Full Article

Wright Medical to settle hip implant cases for $240 million

Wright Medical Group has agreed to pay $240 million to settle nearly 1,300 lawsuits claiming design defects in its metal-on-metal hip implants resulted in patient injuries, the company announced Wednesday.